Nicholas Jacobsen

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Amy C. Thomas, D. Rice, V. Libri, 2021, The Lancet.

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Nigel de Kare-Silver, S. Royal, K. Hood, 2022, The Lancet.

Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.

C. Kerr, S. Rathod, L. Baldock, 2021, Journal of affective disorders.

The impact of treatment-resistant depression on the lives of carers: A mixed-methods study.

C. Kerr, S. Rathod, L. Baldock, 2022, Journal of affective disorders.

The lived experience of major and treatment-resistant depression in England: a mixed-methods study.

S. Rathod, M. Desai, Nicholas Jacobsen, 2023, Acta psychologica.